Skip to main content

Intuitive Surgical



) pushed the Health Services industry higher today making it today's featured health services winner. The industry as a whole closed the day up 0.1%. By the end of trading, Intuitive Surgical rose $4.50 (0.8%) to $544.31 on light volume. Throughout the day, 172,630 shares of Intuitive Surgical exchanged hands as compared to its average daily volume of 304,200 shares. The stock ranged in a price between $536.07-$545.19 after having opened the day at $541.59 as compared to the previous trading day's close of $539.81. Other companies within the Health Services industry that increased today were:

Escalon Medical Corporation



), up 21.6%,

Solta Medical



), up 8.4%,

Skilled Healthcare Group



), up 8%, and

TheStreet Recommends

Alphatec Holdings



), up 7%.

  • ACTIVE STOCK TRADERS: Check out TheStreet's special offer for Real Money, headlined by Jim Cramer, now!

Intuitive Surgical, Inc. designs, manufactures, and markets da Vinci surgical systems for various surgical procedures, including urologic, gynecologic, cardiothoracic, general, and head and neck surgeries. Intuitive Surgical has a market cap of $21.84 billion and is part of the

health care

sector. The company has a P/E ratio of 41.6, equal to the average health services industry P/E ratio and above the S&P 500 P/E ratio of 17.7. Shares are up 16.6% year to date as of the close of trading on Monday. Currently there are five analysts that rate Intuitive Surgical a buy, no analysts rate it a sell, and eight rate it a hold.

TheStreet Ratings rates Intuitive Surgical as a


. The company's strengths can be seen in multiple areas, such as its robust revenue growth, largely solid financial position with reasonable debt levels by most measures, impressive record of earnings per share growth, compelling growth in net income and good cash flow from operations. We feel these strengths outweigh the fact that the company is trading at a premium valuation based on our review of its current price compared to such things as earnings and book value.

On the negative front,

Graymark Healthcare



), down 11.2%,

BioMimetic Therapeutics



), down 10.4%,

Celsion Corporation



), down 9.3%, and

Strategic Diagnostics



), down 9.1%, were all losers within the health services industry with

Thermo Fisher Scientific



) being today's health services industry loser.

For investors not wanting singular stock exposure, ETFs may be of interest. Investors who are bullish on the health services industry could consider

Health Care Select Sector SPDR



) while those bearish on the health services industry could consider

ProShares Ultra Short Health Care